Cargando…
Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)]
The ruthenium-based complex [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane), termed ethaRAPTA, is an interesting antitumor compound. The elucidation of the molecular mechanism of drug activity is central to the drug development program. To this end, we...
Autores principales: | Chakree, Korawan, Ovatlarnporn, Chitchamai, Dyson, Paul J., Ratanaphan, Adisorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497320/ https://www.ncbi.nlm.nih.gov/pubmed/23202946 http://dx.doi.org/10.3390/ijms131013183 |
Ejemplares similares
-
Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017) -
A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
por: Ratanaphan, Adisorn
Publicado: (2012) -
The Significant Influence of a Second Metal on the Antiproliferative Properties of the Complex [Ru(η(6)−C(10)H(14))(Cl(2))(dmoPTA)]
por: Kordestani, Nazanin, et al.
Publicado: (2021) -
Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1
por: Ratanaphan, Adisorn, et al.
Publicado: (2014) -
In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein
por: Atipairin, Apichart, et al.
Publicado: (2011)